Kiek dividendų moka LNA Sante 2025?
Pagal paskutinę informaciją nuo Liepa 2025, LNA Sante per paskutinius 12 mėnesių mokėjo bendrą dividendą, kuris sudarė 0,60 EUR už akciją. Esant dabartiniam LNA Sante kursui 25,78 EUR, tai atitinka 2,33 % dividendų grąžą.
Dividendai mokami kartus per metus.
2,33 % Dividendo grąža | = | 0,60 EUR Dividendas | 25,78 EUR akcijų kaina |
|
Ar LNA Sante dividendai yra saugūs?
LNA Sante kasmet didina dividendus jau 2 metus.
Per pastaruosius 10 metus LNA Sante kasmet 0 % sumažinta.
Per 5 metų laikotarpį augo išmokos padidėjo 9,565 %.
Analitikai prognozuoja, kad einamaisiais verslo metais Dividendų didinimas bus 3,485%.
LNA Sante Aktienanalyse
Ką daro LNA Sante?
LNA Santé SA is a French company specialized in the development, production, and distribution of medical products and services. It was founded in 1991 by Michel Vigor and is headquartered in Saint-Ouen-l'Aumône.
The business model of LNA Santé SA aims to provide high-quality and innovative products and services to patients and medical professionals. The company focuses on comprehensive and tailored consulting, high product quality, and close collaboration with its customers.
LNA Santé SA is divided into several business areas, including homecare, rehabilitation and orthopedics, wound treatment, and intensive care. The company offers a wide range of products and services, tailored to the individual needs of its customers.
In the homecare sector, LNA Santé SA offers a comprehensive range of medical products and services for the outpatient care of patients at home. This includes infusion therapies, enteral nutrition, wound care, and respiratory therapy. Through targeted training and consultations, the company supports both patients and their caregivers in the use of devices and applications.
In the rehabilitation and orthopedics sector, LNA Santé SA provides medical products and services for physical therapy, as well as the supply of prostheses and orthoses. This includes walking aids, wheelchairs, braces, and compression stockings. Through comprehensive consulting and support, the company aims to achieve optimal mobility and quality of life for the patient.
The wound treatment and intensive care sector includes products and services for the care of patients in critical medical situations. This includes ventilation devices, patient monitors, intensive care beds, as well as products for wound care and healing. Again, close collaboration with medical professionals is emphasized to ensure the best possible care for patients.
Overall, LNA Santé SA employs around 800 employees and operates in France, as well as other European countries such as Germany, Belgium, Italy, and Spain. The company focuses on close collaboration with medical institutions such as hospitals, clinics, and nursing services in order to continue offering innovative and tailored products and services in the future.
In summary, LNA Santé SA can be described as an innovative company that focuses on the needs of its customers. Through close collaboration with medical professionals and high quality of products and services, the company ensures optimal patient care. LNA Sante yra viena populiariausių įmonių Eulerpool.com svetainėje.Akcijų taupymo planai siūlo patrauklią galimybę investuotojams ilgalaikėje perspektyvoje kurti turtą. Vienas pagrindinių privalumų yra vadinamasis vidutinės išlaidos efektas: reguliariai investuojant fiksuotą sumą į akcijas arba akcijų fondus, automatiškai perkama daugiau dalinių vertybių popierių, kai kainos yra žemos, ir mažiau – kai jos aukštos. Tai gali lemti palankesnę vidutinę dalies kainą per laiką. Be to, akcijų taupymo planai suteikia galimybę ir smulkiesiems investuotojams patekti į brangias akcijas, nes jie gali dalyvauti jau su mažomis sumomis. Reguliarus investavimas taip pat skatina disciplinuotą investavimo strategiją ir padeda išvengti emociškai pagrįstų sprendimų, pavyzdžiui, impulsyvaus pirkimo ar pardavimo. Be to, investuotojai gauna naudos iš potencialaus akcijų vertės augimo bei iš dividendų, kurie gali būti reinvestuoti, kas sustiprina sudėtinio palūkanų efektą ir taip skatina investuoto kapitalo augimą.